Rigel Pharmaceuticals Inc.


Analysts Change Price Targets for Two Biotech Stocks: Alkermes Plc (ALKS), Rigel Pharmaceuticals, Inc. (RIGL)

Alkermes Plc All eyes today on Alkermes Plc (NASDAQ:ALKS) as the biopharmaceutical company announced positive phase 3 data for ALKS 5461, a pipeline drug …

What Analysts Are Saying About These Two Falling Stocks: Rigel Pharmaceuticals, Inc. (RIGL), DXP Enterprises Inc (DXPE)

Piper Jaffray and William Blair are joining the conversation on falling stocks Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) and DXP Enterprises Inc (NASDAQ:DXPE) after volatile news has …

Stock Update (NASDAQ:RIGL): Here’s Why Rigel Pharmaceuticals, Inc. Shares Are Tumbling 27% Today

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors are having a rough day as the company just reported results from its second phase 3 for fostamatinib in ITP.

Stock Update (NASDAQ:RIGL): Rigel Pharmaceuticals, Inc. Restructures to Focus on Fostamatinib Commercialization

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced plans to build a commercial organization to support the potential launch of fostamatinib, its oral SYK inhibitor, for …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts